Could a common eczema drug help kids grow stronger?
NCT ID NCT07187089
Summary
This study aimed to see if using the approved eczema medication dupilumab could help children with severe eczema grow better and develop stronger bones. It planned to look at children aged 6 to 12 whose eczema was not well-controlled with standard creams. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.